Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Search

Search

Popular Search Terms:
Companies / How to Trade / CEO & Team / Contact / List of Brokers

PPM:JPJ

500.0 GBX

AGRW1:JPJ

2.00 GBX

AGRW2:JPJ

2.0 GBX

AMT:JPJ

80.0 GBX

BIB:JPJ

TBC GBX

BVX:JPJ

10.5 GBX

BLVN:JPJ

0.28 GBX

CDR:JPJ

45.0 GBX

CMB:JPJ

0.45 GBX

CSS:JPJ

12.0 GBX

DEST:JPJ

3.00 GBX

ETX:JPJ

15.0 GBX

ERS:JPJ

5.0 GBX

FCRM:JPJ

0.17 GBX

GEEC:JPJ

4.2 GBX

GSV:JPJ

53.0 GBX

GYG:JPJ

30.15 GBX

HVS:JPJ

5.00 GBX

IBPO:JPJ

59.8 GBX

ITHL:JPJ

475.0 GBX

IPG:JPJ

66.7 GBX

LDSG:JPJ

6.25 GBX

LEXW:JPJ

1.0 GBX

LOOP:JPJ

0.7 GBX

LPM:JPJ

45.0 GBX

MEN:JPJ

7.5 GBX

OMM:JPJ

150.0 GBX

MEAL:JPJ

1.5 GBX

PRAX1:JPJ

1.77 GBX

PRAX2:JPJ

2.0 GBX

QFH:JPJ

2200.0 GBX

QUIZ:JPJ

0.64 GBX

REC:JPJ

0.035 EUR

REDX:JPJ

15.0 GBX

RGH:JPJ

70.0 GBX

SCHO:JPJ

44.0 GBX

SND:JPJ

1.35 GBX

SPO:JPJ

85.0 GBX

SDRY:JPJ

3.29 GBX

TAL:JPJ

3.0 GBX

TNDE:JPJ

2.0 GBX

INGT:JPJ

43.0 GBX

THRV:JPJ

188.0 GBX

PPM:JPJ

500.0 GBX

AGRW1:JPJ

2.00 GBX

AGRW2:JPJ

2.0 GBX

AMT:JPJ

80.0 GBX

BIB:JPJ

TBC GBX

BVX:JPJ

10.5 GBX

BLVN:JPJ

0.28 GBX

CDR:JPJ

45.0 GBX

CMB:JPJ

0.45 GBX

CSS:JPJ

12.0 GBX

DEST:JPJ

3.00 GBX

ETX:JPJ

15.0 GBX

ERS:JPJ

5.0 GBX

FCRM:JPJ

0.17 GBX

GEEC:JPJ

4.2 GBX

GSV:JPJ

53.0 GBX

GYG:JPJ

30.15 GBX

HVS:JPJ

5.00 GBX

IBPO:JPJ

59.8 GBX

ITHL:JPJ

475.0 GBX

IPG:JPJ

66.7 GBX

LDSG:JPJ

6.25 GBX

LEXW:JPJ

1.0 GBX

LOOP:JPJ

0.7 GBX

LPM:JPJ

45.0 GBX

MEN:JPJ

7.5 GBX

OMM:JPJ

150.0 GBX

MEAL:JPJ

1.5 GBX

PRAX1:JPJ

1.77 GBX

PRAX2:JPJ

2.0 GBX

QFH:JPJ

2200.0 GBX

QUIZ:JPJ

0.64 GBX

REC:JPJ

0.035 EUR

REDX:JPJ

15.0 GBX

RGH:JPJ

70.0 GBX

SCHO:JPJ

44.0 GBX

SND:JPJ

1.35 GBX

SPO:JPJ

85.0 GBX

SDRY:JPJ

3.29 GBX

TAL:JPJ

3.0 GBX

TNDE:JPJ

2.0 GBX

INGT:JPJ

43.0 GBX

THRV:JPJ

188.0 GBX

Category: BVX

Proposed Voluntary Delisting

BiVictriX Therapeutics PLC 12 August 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information is now […]

BiVictriX Therapeutics plc Shares now trading on JP Jenkins

11th Sept 2024 JPJ: BVX ISIN: GB00BNXH3K91 BiVictriX Therapeutics plc (“BiVictriX” or the “Company”) Shares now trading on JP Jenkins London, UK. 11th Sept July 2024 – BiVictriX Therapeutics plc (JPJ: BVX), a drug discovery and development company applying an innovative, proprietary approach to develop a new class of highly selective, next generation cancer therapeutics, bispecific […]

0207 469 0937

info@jpjenkins.com

5th Floor
101 Wigmore St
London
W1U 1QU

Linkedin Facebook X-twitter

Copyright © 2023 JP Jenkins. All rights reserved. JP Jenkins is a trading name of Infinitx Limited a company incorporated in England & Wales with registered number 11551708 and whose registered office is at 101 Wigmore Street, 5th Floor, London, England, W1U 1QU (JPJ). JPJ (FRN 950991) is an appointed representative of Prosper Capital LLP (FRN453007) (Prosper) which is authorised and regulated by the Financial Conduct Authority. This website is a financial promotion by JPJ. It is not intended to be a promotion of any individual investment opportunity and is not an offer to the public. JPJ acts for the companies listed on the website and provides services to authorised brokers but does not act for investors, consumers or any other person. The information on this website is obtained from the companies and other third parties and although JPJ considers these sources to be reliable, it makes no representation as to the accuracy of the information. Neither JPJ, Prosper nor any member of their group provides any advice on investing in unlisted shares generally or in the companies listed on the platform specifically, nor any legal, financial or tax advice of any kind. Nothing on this website and no communication from JPJ should be construed as an investment recommendation. If you have any doubt about the suitability of the investment, or you require financial advice, you should seek a personal recommendation from an appropriately qualified financial advisor. Investing in unlisted shares is high risk and should only be done as part of a diversified portfolio. Please read the RISK WARNINGS before making any investment decisions. Offers are only available through authorised persons. Any person resident outside the United Kingdom should ensure that they are not subject to any local regulations before investing. Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. If you have any questions regarding these matters relating to information on this website you should consult a professional adviser.